marketinference43m
Beigene Appoints Shalini Sharp to Board
(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, recently announced the appointment of Shalini Sharp to its board of directors, effective Septemb ...
americanjournalnews4h
Big pharma ties raise conflict of interest concerns for GOP's Prasanth Reddy
U.S. House candidate Prasanth Reddy has taken large sums of money from the pharmaceutical industry throughout his career. Some of these companies have tried to block legislation aimed at lowering ...
manilatimes7h
Organon underscores importance of contraceptive education on World Contraception Day
ON World Contraception Day, Organon, a pharmaceutical company focused on women's health, ignited discussions on women's ...
Organon Canada and the Alberta Women's Health Foundation unite to raise awareness and advocate for universal access to contraception in Canada
In recognition of World Contraception Day (WCD) on September 26, Organon Canada, a subsidiary of Organon (NYSE: OGN), a ...
Impacts8h
BeiGene Appoints Shalini Sharp to Board of Directors
BeiGene has appointed Shalini Sharp to the Board of Directors and as a member of the Board’s Audit Committee. Takeaway Points ...
Joplin Globe11h
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Shalini Sharp to its Board of Directors and as a member of the Board’s Audit Committee, ...
bovnews1d
Organon & Co (OGN) Stock: More Robust Than the Numbers Suggest?
Organon & Co (OGN) stock saw a decline, ending the day at $19.66 which represents a decrease of $-0.06 or -0.30% from the prior close of $19.72. The stock opened at $19.8 and touched a low of $19.51 ...
Zacks.com on MSN1d
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
BioPharma Dive2d
Bluebird to lay off another 25% of workforce in latest restructuring
The announced job cuts are the latest in a series of steps Bluebird has taken to preserve cash and break even financially amid slow uptake of its marketed gene therapies.
Becker's Hospital Review3d
Federal court revives hundreds of lawsuits over osteoporosis drug
A U.S. appeals court has reinstated more than 500 lawsuits against drugmaker Merck & Co. because of its osteoporosis drug Fosamax, which plaintiffs allege increases risk of thigh bone fractures, ...
kffhealthnews3d
Many Lawsuits Over Femur Risks Of Merck Drug Fosamax Can Now Proceed
Fosamax was acquired in 2021 by Organon, which agreed to indemnify Merck against liability from the lawsuits. (Pierson, 9/20) Reuters: J&J Unit Files For Bankruptcy To Advance $10 Billion Talc ...
Barron's3d
Organon & Co.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...